Cancer type | Liver | Lung | Colorectal | Lymphatic and haematopoietic tissue | Breast | Others |
---|---|---|---|---|---|---|
HR (95 % CI) | HR (95 % CI) | HR (95 % CI) | HR (95 % CI) | HR (95 % CI) | HR (95 % CI) | |
Comparison cohort | ref | ref | ref | ref | ref | ref |
AHA cohort | 1.23(0.77–1.98) | 1.28(0.73–2.23) | 1.16(0.65–2.07) | 13.1(8.46–20.3) | 1.13(0.55–2.30) | 1.82(1.40–2.35) |
Non-AIHA | 1.43(0.84–2.43) | 1.24(0.62–2.46) | 1.28(0.65–2.50) | 9.59(5.57–16.5) | 1.23(0.53–2.88) | 1.81(1.34–2.46) |
AIHA | 0.91(0.41–2.01) | 1.35(0.55–3.30) | 0.95(0.35–2.61) | 19.5(11.5–32.8) | 0.98(0.34–2.85) | 1.82(1.22–2.73) |